Option Care Health (OPCH)
(Delayed Data from NSDQ)
$29.61 USD
+0.32 (1.09%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $29.61 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$29.61 USD
+0.32 (1.09%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $29.61 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth A Momentum B VGM
Zacks News
Option Care (OPCH) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Option Care (OPCH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Option Care (OPCH) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 11.11% and 1.01%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
New Strong Buy Stocks for November 3rd
by Zacks Equity Research
CNX, DOW, SNDR, HLIT, and OPCH have been added to the Zacks Rank #1 (Strong Buy) List on November 3, 2021.
Option Care (OPCH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Option Care (OPCH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 High-Potential MedTech Stocks With More Than 50% Growth YTD
by Riya Anand
Stocks like West Pharmaceuticals Services (WST), Maravai LifeSciences (MRVI) and Option Care Health (OPCH) have gained stupendously year to date.
Option Care (OPCH) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Option Care (OPCH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Top Ranked Momentum Stocks to Buy for September 14th
by Zacks Equity Research
RRC, OPCH, CNQ, and ARES made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 14, 2021.
What Makes Option Care (OPCH) a Good Fit for "Trend Investing"
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Option Care (OPCH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
3 MedTech Sectors Benefiting Despite COVID-19 Resurgence
by Urmimala Biswas
Here we discuss three major subsectors of MedTech and some of their constituent stocks for which COVID-19 has opened up enormous growth prospects.
Can Option Care (OPCH) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Option Care (OPCH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Recent Price Trend in Option Care (OPCH) is Your Friend, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Option Care (OPCH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
New Strong Buy Stocks for August 16th
by Zacks Equity Research
CVLG, DDS, MHO, OPCH, and TUP have been added to the Zacks Rank #1 (Strong Buy) List on August 16, 2021.
Option Care (OPCH) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 125.00% and 9.19%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Option Care (OPCH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Option Care (OPCH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Option Care (OPCH) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of -200.00% and 0.80%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Is Option Care Health (OPCH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (OPCH) Outperforming Other Medical Stocks This Year?
Option Care (OPCH) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 42.86% and 0.49%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Option Care (OPCH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Option Care (OPCH) closed at $19.54 in the latest trading session, marking a -1.19% move from the prior day.
What's in Store for Fulgent Genetics (FLGT) in Q4 Earnings?
by Zacks Equity Research
We expect strong demand for Fulgent Genetics' (FLGT) end-to-end tests for COVID-19 to have continued through the fourth quarter.
DENTSPLY SIRONA (XRAY) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect weak segmental performance.
Option Care (OPCH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Option Care (OPCH) closed at $18.97, marking a +0.58% move from the previous day.
Is Option Care Health (OPCH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (OPCH) Outperforming Other Medical Stocks This Year?
Owens & Minor (OMI) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
We expect the strength in demand for Owens & Minor's (OMI) PPEs to have continued through the fourth quarter.
Option Care (OPCH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Option Care (OPCH) closed the most recent trading day at $19.86, moving +0.2% from the previous trading session.
Lower Bulk Purchases May Weigh on Medtronic (MDT) Q3 Earnings
by Zacks Equity Research
Medtronic's (MDT) diabetes care, robotics surgery and neuromodulation lines are expected to have performed well in Q3.